Patterns of molecular activity in the blood may hold clues not only to how fit someone is, but also to the biological ...
EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced p ...
Morning Overview on MSN
Scientists discover a single protein that forces the brain to clean out its own Alzheimer’s plaques
A Colombian man carried one of the most aggressive genetic mutations known to cause early-onset Alzheimer’s disease. By all ...
New research shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was low, ...
As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA to the liver, they created a temporary source of immune-boosting signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results